Sanofi is interested in Recludix Pharma’s approach to treating inflammation with an oral small molecule that targets a protein thought to be undruggable. If it works, the drug could have safety and dosing advantages over currently available biologic drugs, including blockbuster Sanofi drug Dupixent.
The at-home care field holds significant market potential. As the subsector continues to grow, some leaders of home healthcare startups are challenging misconceptions that some other industry stakeholders may still have, including the misbelief that at-home care is only for senior citizens and that this care model lacks scalability.
Early-stage healthcare innovation fund Jumpstart Foundry is accepting Fall funding applications through September 30th. Read on to find out why Jumpstart Foundry could be the missing piece in your startup’s journey to making a lasting difference in healthcare.
Tenpoint Therapeutics’ name refers to the time it takes for an image to hit the retina and be processed by the brain. The regenerative medicine startup is developing cell therapies it hopes restore that vision capability for patients with degenerative eye disorders.
Sonio recently gained $14 million in Series A funding. The Paris-based startup’s AI platform automates ultrasound reporting so that healthcare providers can conduct ultrasound exams with greater accuracy, speed and efficiency.
Septerna Therapeutics’ Series B financing will support plans to reach the clinic with a pill for a rare disease whose only approved therapy is a Takeda Pharmaceutical drug that’s leaving the market. Potential rival therapies are all injectables.
Neko Health recently raised €60 million (about $65.8 million) in Series A financing. The Stockholm-based startup’s medical scanning technology aims to conveniently and affordably collect extensive health data to aid doctors in catching diseases early. The company’s scan takes about 10 minutes and costs €250 (about $275).
A new cohort of startups has graduated from PharmStars, a digital health accelerator. This latest group focused on women’s health and health equity.
BeeKeeperAI — which offers a platform to facilitate the development and deployment of healthcare AI models — raked in $12.1 million in Series A funding led by Santé Ventures. The startup was spun out of UCSF last year.
Providence spinout DexCare recently closed a $75 million Series C funding round, bringing its total funding to date to $146 million. The startup gives health systems a platform that helps them coordinate and manage digital care services so they can better address the modern healthcare consumer’s demands for convenience and immediacy.
Scientists at Empress Therapeutics say molecules that co-evolved with humans over millennia are a promising source of new drugs. With its AI-driven technology platform, the Flagship Pioneering-founded startup finds them.
A new startup named Zuri Fertility recently launched. Its platform provides resources for patients who are trying to conceive — including telehealth, at-home testing, prescriptions, mental health services, education and care coordination.
Renee Dua and Nick Desai —the husband-and-wife duo who founded physician house call company Heal in 2014 — have launched another healthcare startup. The company, called Together by Renee, said it is the first app to use generative AI to manage time-consuming healthcare tasks for older patients, those with chronic diseases and their stressed-out caregivers.
Medivis recently raised $20 million in a Series A funding round that included investments from Mayo Clinic, Bob Iger and Kevin Durant. The New York City-based company’s technology can be thought of as a “virtual GPS system” for surgeons — it helps them navigate complex anatomical landscapes during operations and gives them a more accurate, intuitive understanding of the anatomy with which they’re dealing.
Laudio — a startup providing software that automates administrative tasks for frontline nurse managers — recently raised $13 million in Series B funds. The company’s platform helps managers complete tasks like patient rounding and schedule making more quickly, as well as provides recommendations on how to better engage staff members.
AstraZeneca is paying $85 million to kick off an alliance with Quell Therapeutics focused on developing new cell therapies for autoimmune diseases. Type 1 diabetes and inflammatory bowel disease are the focus of the research collaboration.